MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Eli Lilly and Company (Details)	1 Months Ended	12 Months Ended
	Apr. 30, 2025 USD ($) target	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Revenues		$ 39,552,000	$ 57,800,000
Deferred revenues		899,000	$ 7,556,000
Eli Lilly and Company | License
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Number of targets | target	1
Number of additional targets | target	4
Contract with customer liability	$ 18,000,000.0
Variable consideration amount	$ 1,400,000,000
Revenue from contract with customer, number of potential targets | target	5
Royalty obligation, term	10 years
Revenues		18,000,000.0
Deferred revenues		$ 0